Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessTuberculosis

High-throughput automated microfluidic sample preparation for accurate microbial genomics

Nature Communications·

Soohong Kim, Joachim De Jonghe, Anthony B. Kulesa, David Feldman, Tommi Vatanen, Roby P. Bhattacharyya, Brittany Berdy, James Gomez, Jill Nolan, Slava Epstein, Paul C. Blainey

DOI
10.1038/ncomms13919
PMID
28128213
PMCID
PMC5290157
OpenAlex
W2580767916
Study type
Genomic study
Publisher
Springer Science and Business Media LLC
Article type
journal-article
Integrity
current

Why this research matters now

The technology enables broader deployment of microbial genomics for tuberculosis and antimicrobial resistance surveillance by overcoming sample quantity barriers and improving throughput for clinical pathogen sequencing.

01

Structured evidence summary

Research question

The study aimed to develop and validate a high-throughput microfluidic platform that integrates sample preparation steps for microbial genomic sequencing while reducing DNA input requirements.

Study design

The authors designed a microfluidic system supporting up to 96 samples and tested it with whole-genome shotgun sequencing of Mycobacterium tuberculosis, soil micro-colonies, and approximately 400 clinical Pseudomonas aeruginosa isolates.

Population and setting

The platform was applied to clinical Pseudomonas aeruginosa samples and laboratory cultures of Mycobacterium tuberculosis and soil micro-colonies requiring low DNA input.

Main findings

The microfluidic platform reduced DNA input requirements 100-fold while maintaining or improving data quality. Low-input whole-genome sequencing of M. tuberculosis and soil micro-colonies produced superior results. Sequencing of clinical P. aeruginosa libraries demonstrated excellent single-nucleotide polymorphism detection that explained phenotypically observed antibiotic resistance.

Public-health relevance

The technology enables broader deployment of microbial genomics for tuberculosis and antimicrobial resistance surveillance by overcoming sample quantity barriers and improving throughput for clinical pathogen sequencing.

Important limitations

This summary is limited to the supplied single-article abstract and metadata. The original paper is required for decision-grade interpretation of validation scope, reproducibility across settings, and operational constraints.

GIDS interpretation

The article was indexed under tuberculosis, antimicrobial resistance, and genomic epidemiology topics, reflecting its methodological contribution to pathogen whole-genome sequencing workflows rather than reporting outbreak or surveillance findings.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 7 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseaddresses topicaddresses topicaddresses topichas pathogen typestudied population settinguses study design